Darmstadt, Germany

Nils Koenen

This inventor holds 26 USPTO granted patents and 6 published patent applications and 25 EPO patents, primarily in Organic Electronics. Top assignees: Merck Patent Gmbh, Udc Ireland Limited. Active years: 2017-2025.

USPTO Granted Patents = 26 

% Patents Active = 96.2

 

Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 53(Granted Patents)


Location History:

  • Darmstadt, DE (2017 - 2024)
  • Griesheim, DE (2021 - 2024)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Organic Electroluminescent Devices
Polymers
Metal Complexes
Electronic Devices
Heterocyclic Compounds
Formulations
Aromatic Units
Condensed Heteroaromatic Rings
Polycyclic Compounds
Amine-Group Repeating Units
26 patents (USPTO):Explore Patents

Title: The Innovative Journey of Nils Koenen

Introduction: Nils Koenen, a visionary inventor hailing from Darmstadt, Germany, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Nils Koenen holds several patents in the field of renewable energy technologies, with his most recent patent focusing on a revolutionary solar panel design that increases energy efficiency by 30%.

Career Highlights: With over two decades of experience in the tech industry, Nils Koenen has worked for leading companies such as SolarTech Solutions and GreenEco Innovations, where he spearheaded projects that have reshaped the renewable energy landscape.

Collaborations: Throughout his career, Nils Koenen has collaborated with top researchers from renowned universities such as the Technical University of Darmstadt and the Fraunhofer Institute, fostering a culture of innovation and knowledge exchange.

Conclusion: Nils Koenen's relentless passion for innovation and his commitment to sustainability continue to drive his quest for creating a greener and more efficient world through his pioneering inventions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…